Michael Clarke, Medicine (Oncology)
Molecular and Functional Characterization of Colon Tumor Cancer Stem Cells and Stroma
Michael Clarke - Karel H. & Avice N. Beekhuis Professor of Cancer Biology
Bio-X Affiliated Faculty
Dr. Clarke's laboratory is focused on two areas of research: the control of self-renewal of normal stem cells and their malignant counterparts; and the identification and characterization of cancer stem cells.
Stanford Bio-X Seed Grants
Interdisciplinary Initiatives Program Seed Grant: Decoding Tumor Initiating Cells in Breast Cancer by Digital Cytometry
Interdisciplinary Initiatives Program Round 9 - 2018
Molecular and Functional Characterization of Colon Tumor Cancer Stem Cells and Stroma
Interdisciplinary Initiatives Program Round 3 – 2006
Adaptation of a Miniature Microscope for the Noninvasive In Vivo Detection of Rare Circulating Tumor Cells in the Vasculature
Interdisciplinary Initiatives Program Round 6 - 2012
Research News
Stanford study provides new understanding of breast growth disorders
May 4, 2017 - Stanford Medicine Scope
Bio-X affiliates Philip Beachy and Michael Clarke have discovered a new way that the GLI2 gene impacts breast...
Cancer uses inflammatory pathways to protect itself
April 11, 2017 - Stanford Medicine Scope
Bio-X affiliates Irv Weissman, Michael Clarke, and Nicholas Leeper have discovered that cancer cells...
Hedgehog pathway plays a role in colitis, new research suggests
November 2, 2016 - Stanford Medicine Scope
Researchers under Bio-X affiliates James Chen, Maximilian Diehn, Michael Clarke, and Philip Beachy have...